Skip to main content
Elsevier
View Cart
openUserAccount

Books in Oncology

BooksJournals
101-110 of 111 results in All results

Cancer Emergencies, Part II, An Issue of Emergency Medicine Clinics

  • 1st Edition
  • Volume 27-3
  • August 27, 2009
  • David M. Spiro + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 2 1 1 - 7
Doctors Daya and Spiro concluded the two part series on Cancer Emergencies with articles on: "GI Bleeding," "Hepatic Encephalopathy," "Bleeding diatheses, Disseminated intravascular coagulation," "Hyperviscosity syndrome, Polycythemia, Hyperleukocytosis, Thrombocytosis," and more!

Neoplastic Hematopathology, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 23-4
  • July 31, 2009
  • Randy D. Gascoyne
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 1 2 2 6 - 1
This issue focuses on neoplastic hematopathology. Thirteen articles written by leading experts in the field cover a number of specific disease entities including the acute leukemias, myelodysplastic syndromes, myeloproliferative diseases, multiple myeloma and the chronic lymphoid leukemias. The spectrum of lymphoid cancers and related disorders is also covered, including articles on reactive and atypical lymphoproliferative disorders, Hodgkin lymphoma, small B cell malignancies, the aggressive B cell lymphomas, as well as Burkitt lymphoma and the entire spectrum of peripheral T cell lymphomas. Finally, two more generic articles cover current issues in bone marrow pathology for lymphoma diagnosis and staging and finally a cutting-edge chapter on molecular diagnostics in hematopathology.

Advances in Melanoma, An Issue of Hematology/Oncology Clinics

  • 1st Edition
  • Volume 23-3
  • June 18, 2009
  • David E. Fisher
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 4 8 8 - 4
The field of melanoma biology has experienced a remarkable surge in recent years, owing to progress which has ranged from the most basic laboratory/preclinical discoveries to clinical developments that have begun to transform the management and prognosis for at least certain melanoma patients. Among the key areas that have contributed to this progress are studies relating to signaling and transcriptional pathways that regulate control over differentiation and survival of the melanocyte lineage. The identification of recurring activating mutations in specific signaling factors (B-RAF, N-Ras, c-KIT), amplification of other melanoma oncogenes (MITF, NEDD9), and the crucial recognition that certain of these genomic events occur within melanomas arising with specific clinical features (eg mucosal or acral origin) have led to clear recognition that melanoma is indeed “many different diseases.” While the various subclasses of melanoma may share common features, such as profound invasive and metastatic propensity, it is also likely that sharply focused therapeutic strategies may exploit the functionally critical molecular engines, which distinguish these subclasses. Certain strategies focus upon the immunogenicity and striking clinical opportunities afforded by immune modulation, while others focus more directly on tumor-specific targeting. This issue brings together some of the leaders who have contributed significant insights from basic melanoma biology to progress in the clinic.

Bone Marrow Failure Syndromes, An Issue of Hematology/Oncology Clinics

  • 1st Edition
  • Volume 23-2
  • April 22, 2009
  • Grover C. Bagby + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 4 8 7 - 7
The bone marrow failure syndromes include a group of disorders than can be either inherited or acquired. These diseases are disorders of the hematopoietic stem cell that can involve either one cell line or all of the cell lines (erythroid for red cells, myeloid for white blood cells, megakaryocytic for platelets). The lymphocytes, which are involved in lymphoproliferative disorders, are usually spared. The inherited bone marrow failure syndromes include Fanconi anemia, dyskeratosis congenital, Diamond-Blackfan anemia, and other genetic disorders. The most common cause of acquired bone marrow failure is aplastic anemia. Expert authors present current diagnosis, treatment, and management strategies for these syndromes. The articles in this issue are divided into 3 classifications: global marrow failure, lineage-restricted marrow failure, and marrow failure and evolution of neoplastic clones.

Biliary Tract Cancers, An Issue of Surgical Oncology Clinics

  • 1st Edition
  • Volume 18-2
  • April 22, 2009
  • Joseph J. Bennett
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 9 1 2 - 4
Proposed topics for this issue include: Malignant Masquerade: Dilemmas in Diagnosing Biliary Obstruction; Molecular Mechanisms of Cholangiocarcinogenesis; Multimodality Imaging of Biliary Malignancies; Percutaneous Approach to the Diagnosis and Treatment of Biliary Tract Malignancies; Portal Vein Embolization in Hilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma: Current surgical strategy; Management and Extent of Resection for Intrahepatic Cholangiocarcinoma; Surgical Management of Gallbladder Cancer; Transplantation for Cholangiocarcinoma: When and for Whom?; Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy; Indications for neoadjuvant, adjuvant and palliative chemotherapy in the treatment of biliary tract cancers.

Clinical Update on Adult and Pediatric Gastrointestinal Stromal Tumor, An Issue of Hematology/Oncology Clinics

  • 1st Edition
  • Volume 23-1
  • March 23, 2009
  • Jonathan C. Trent + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 0 4 8 6 - 0
Most doctors believe gastrointestinal stromal tumors (GISTs) start in special cells found in the wall of the GI tract, called the interstitial cells of Cajal (ICCs), or in very early cells that can develop into ICCs. ICCs are part of the autonomic nervous system, which sends signals to the GI tract. Some have called these cells the "pacemakers" of the GI tract because the nerve signals they send cause muscles of the digestive organs to contract, which helps to move food and liquid through the GI tract. This issue is an important one because GISTs are rare and are quite different in their outlook for survival and their treatment than other gastrointestinal tumors. For these reasons, oncologists need to figure out whether a patient has a GIST, an adenoma, an adenocarcinoma, a neuroendocrine cancer, some other type of tumor, or a non-cancerous condition. By presenting state-of-the-art information on the diagnosis, treatment, and management of GISTs, this issue serves as an important guide to oncologists as they work with patients to make make informed decisions about treatment options.

Suivi médical du patient traité pour un cancer

  • 1st Edition
  • September 1, 2008
  • Nicolas Daly-Schveitzer
  • French
  • eBook
    9 7 8 - 2 - 9 9 4 0 9 8 6 - 7 - 6
Les traitements des cancers permettent d'obtenir aujourd'hui la guérison d'un patient sur deux et, à défaut, une prolongation substantielle de la survie des autres patients malgré l'évolution de leur maladie. Aussi, le suivi et l'accompagnement du patient traité pour un cancer occupent une place de plus en plus importante notamment dans le domaine de la médecine de ville. Ceci oblige le praticien à maîtriser les différents aspects de ces pathologies ainsi que ceux des effets secondaires immédiats et retardés de leurs traitements. En effet, entre deux traitements ou hospitalisations, après le traitement et alors souvent pendant des années, c'est au médecin de ville qu'incombe l'essentiel du suivi et de l'accompagnement. Articulé en trois parties, avant, pendant et après le traitement, cet ouvrage rassemble toutes les informations nécessaires à un suivi efficace du patient. Il traite particulièrement des conséquences symptomatiques des maladies et de leurs traitements dans le but de les réduire et souvent de les prévenir.

Acute Care Oncology Nursing

  • 2nd Edition
  • April 24, 2008
  • Cynthia C. Chernecky + 1 more
  • English
  • Paperback
    9 7 8 - 1 - 4 1 6 0 - 3 7 3 4 - 7
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 1 0 0 5 - 8
As the likely first responder in an emergency, you need quick access to essential information on the potential complications of many different cancer types and treatments. The new edition of this trusted resource provides up-to-date information on the pathophysiology, complications, risks, treatment approaches, prognosis, assessment findings, and nursing and medical interventions for a wide range of cancers. It also offers valuable information to help you fulfill your role as care coordinator and patient advocate, including client education guidelines, discharge procedures, and strategies for helping the client and family deal with the impact of the disease’s progression.

Mosby's Oncology Nursing Advisor

  • 1st Edition
  • April 10, 2008
  • Susan Maloney-Newton + 2 more
  • English
  • eBook
    9 7 8 - 0 - 3 2 3 - 0 7 9 3 4 - 1
Like getting 7 books in 1, MOSBY'S ONCOLOGY NURSING ADVISOR provides quick access to essential information on a wide range of cancer topics, including types of cancer, treatment options, symptom management, palliative care, and patient teaching. Its user-friendly layout and straightforward coverage make it ideal for use in any clinical setting, offering authoritative guidance to help you provide the best possible oncology nursing care.

Oncology Nursing

  • 5th Edition
  • April 4, 2007
  • Martha Langhorne + 2 more
  • English
  • Paperback
    9 7 8 - 0 - 3 2 3 - 0 4 1 8 5 - 0
This classic text offers a comprehensive, yet concise and manageable overview of oncology nursing. New to this edition, symptom management topics are now presented in a separate unit so you'll easily see how to effectively improve your patients' sense of wellbeing. Over 400 multiple-choice review questions complement chapter case studies to reinforce what you've learned as well as prepare you for certification exams.